En tilgang til udfordringer i et travlt fosterdiagnostikcenter midt i en

Diagnostisk RET-genetisk testning hos 1.058 indekspatienter: et britisk centerperspektiv

Goal: Diagnostic germline RET evaluation is obtainable to all sufferers with a prognosis of medullary thyroid carcinoma (MTC), or different situations related to a number of endocrine neoplasia kind 2 (MEN2) in the UK. Right here we report the expertise of a single centre’s germline RET evaluation over a 21-year interval.
Design: Retrospective case-note assessment PATIENTS: All index sufferers referred to the Exeter Genomics Laboratory for diagnostic germline RET evaluation between 1997 and 2018, and unaffected relations, present process predictive testing.
Measurements: The speed and nature of pathogenic variant detection was recorded, in addition to the indication for testing.
Outcomes: 1,058 index sufferers and 551 unaffected relations have been examined. The general charge of pathogenic variant detection was 10.2% amongst index sufferers, and 29% amongst unaffected relations.
The most common indication was remoted MTC, and amongst the 690 sufferers with remoted MTC, 68 (9.9%) have been discovered to harbour a RET pathogenic variant. Of these with presumed sporadic MTC, 8.5% have been discovered to harbour germline RET pathogenic variants, in contrast with 36.4% of these with a household historical past of MEN2-associated situations. Pathogenic variants have been recognized in 3.6% and 0% of sufferers with remoted phaeochromocytoma and first hyperparathyroidism respectively.
Conclusions: Though the detection charge of RET germline pathogenic variants in sufferers with presumed sporadic MTC was important, the general detection charge in these with MTC was decrease than anticipated on this collection. Advances in RET evaluation in response to stories of latest variants over the past 20 years are prone to have improved the pick-up charge in recent times.
Key phrases: Hyperparathyroidism; A number of Endocrine Neoplasia Sort 2a; A number of Endocrine Neoplasia Sort 2b; Phaeochromocytoma; Proto-oncogene proteins; c-ret; carcinoma; genetic testing; medullary; main.
cidic
cidic
 
Coxsackievirus B5 protein
30-1334 100 ug
EUR 398
Description: Purified native Coxsackievirus B5 protein (Faulkener Strain)
Cytochrome B5 antibody
20R-CG009 100 ul
EUR 457
Description: Goat polyclonal Cytochrome B5 antibody
Serpin B5 Antibody
34298-100ul 100ul
EUR 252
Serpin B5 Antibody
34298-50ul 50ul
EUR 187
Gluten Exorphin B5
5-01227 4 x 5mg Ask for price
Vitamin B5 [HRP]
DAGA-123H 1mg
EUR 1222
Vitamin B5 [KLH]
DAGA-123K 1mg
EUR 1235
Serpin B5 antibody
70R-50205 100 ul
EUR 244
Description: Purified Polyclonal Serpin B5 antibody
Serpin B5 antibody
70R-33858 100 ug
EUR 327
Description: Rabbit polyclonal Serpin B5 antibody
K6H6/B5 cells
C0033002 One Frozen vial
EUR 543
B5 Receptor Antibody
abx430923-200ul 200 ul
EUR 384
  • Shipped within 1-3 working days.
Cytochrome b5 Antibody
abx232186-100ug 100 ug
EUR 481
  • Shipped within 5-12 working days.
Gluten Exorphin B5
H-1666.0025 25.0mg
EUR 576
Description: Sum Formula: C30H38N6O7; CAS# [68382-18-3]
Gluten Exorphin B5
H-1666.0100 100.0mg
EUR 1663
Description: Sum Formula: C30H38N6O7; CAS# [68382-18-3]
anti-Cytochrome b5
YF-PA11223 50 ul
EUR 363
Description: Mouse polyclonal to Cytochrome b5
anti-Cytochrome b5
YF-PA23551 50 ul
EUR 334
Description: Mouse polyclonal to Cytochrome b5
Mounting Medium
4300 3 ml
EUR 180.5
Description: This is Mounting medium (non-fading) used for maintaining optimal conditions needed to obtain the maximum fluorescence emission from Fluorescein.
VALI Medium
450 500 ml
EUR 265
BEGM Medium
451 500 ml
EUR 152
DC MEDIUM
D04-117-10kg 10 kg
EUR 1579
DC MEDIUM
D04-117-2kg 2kg
EUR 382
DC MEDIUM
D04-117-500g 500 g
EUR 140
EC MEDIUM
E05-100-10kg 10 kg
EUR 814
EC MEDIUM
E05-100-2Kg 2 Kg
EUR 216
EC MEDIUM
E05-100-500g 500 g
EUR 95
Advanced Medium
C0003-04 RT 500 mL Bottle
EUR 103
Medium 199
C0012-01 RT 500 mL Bottle
EUR 105
COLIFORM MEDIUM
C03-127-10kg 10 kg
EUR 1324
COLIFORM MEDIUM
C03-127-2kg 2kg
EUR 327
COLIFORM MEDIUM
C03-127-500g 500 g
EUR 125
Heller's Medium
CP014-010 10X1L
EUR 99
Heller's Medium
CP014-500 50L
EUR 126
Hoagland's Medium
CP015-010 10X1L
EUR 99
Hoagland's Medium
CP015-500 50L
EUR 126
HLP MEDIUM
H08-107-10kg 10 kg
EUR 2278
HLP MEDIUM
H08-107-2Kg 2 Kg
EUR 534
HLP MEDIUM
H08-107-500g 500 g
EUR 182
NeuroProgenitor Medium
NM42400 125 ml
EUR 304
SIM MEDIUM
S19-110-10kg 10 kg
EUR 1021
SIM MEDIUM
S19-110-2kg 2kg
EUR 261
SIM MEDIUM
S19-110-500g 500 g
EUR 107
SOB MEDIUM
S19-124-10kg 10 kg
EUR 965
SOB MEDIUM
S19-124-2kg 2kg
EUR 249
SOB MEDIUM
S19-124-500g 500 g
EUR 104
A Medium
DJ1018 100g
EUR 84.8
  • Product category: Culture Media/Medium
M9 Medium
SD7024 250g
EUR 71.75
  • Product category: Culture Media/Medium
M9CA Medium
SD7025 250g
EUR 71.75
  • Product category: Culture Media/Medium
YM Medium
SD7031 250g
EUR 70.45
  • Product category: Culture Media/Medium
TYGPN Medium
SD7032 250g
EUR 70.01
  • Product category: Culture Media/Medium
M63 Medium
SD7033 250g
EUR 71.75
  • Product category: Culture Media/Medium
Monoclonal Proinsulin Antibody (Clone HPI-B5), Clone: HPI-B5
AMR09558G 0.1mg
EUR 484
Description: A Monoclonal antibody against Human Proinsulin (Clone HPI-B5). The antibodies are raised in Mouse and are from clone HPI-B5. This antibody is applicable in WB and IHC, E
Monoclonal GLP-1 Antibody (Clone HGL-B5), Clone: HGL-B5
AMM04792G 0.1mg
EUR 484
Description: A Monoclonal antibody against Human GLP-1 (Clone HGL-B5). The antibodies are raised in Mouse and are from clone HGL-B5. This antibody is applicable in IF, E
Human Cytochrome b5 Antibody
33293-05111 150 ug
EUR 261
Polyclonal Serpin B5 Antibody
APR05559G 0.1ml
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Serpin B5 . This antibody is tested and proven to work in the following applications:
Serpin B5 (SERPINB5) Antibody
20-abx008867
  • EUR 300.00
  • EUR 439.00
  • EUR 189.00
  • 100 ul
  • 200 ul
  • 30 ul
  • Shipped within 5-10 working days.
Serpin B5 (SERPINB5) Antibody
20-abx115469
  • EUR 732.00
  • EUR 398.00
  • 150 ul
  • 50 ul
  • Shipped within 5-10 working days.
Serpin B5 (SERPINB5) Antibody
20-abx127043
  • EUR 411.00
  • EUR 592.00
  • 100 ul
  • 200 ul
  • Shipped within 5-10 working days.
Serpin B5 (SERPINB5) Antibody
abx038026-100ug 100 ug
EUR 391
  • Shipped within 5-10 working days.
Cytochrome B5 (CYB5) Antibody
20-abx014018
  • EUR 314.00
  • EUR 98.00
  • EUR 398.00
  • EUR 495.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg
  • Shipped within 5-10 working days.
Serpin B5 (SERPINB5) Antibody
20-abx014060
  • EUR 314.00
  • EUR 98.00
  • EUR 398.00
  • EUR 495.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg
  • Shipped within 5-10 working days.
Serpin B5 Blocking Peptide
20-abx063080
  • EUR 272.00
  • EUR 411.00
  • 1 mg
  • 5 mg
  • Shipped within 5-10 working days.
Gluten Exorphin B5 Peptide
20-abx265771
  • EUR 328.00
  • EUR 495.00
  • EUR 272.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.
Polyclonal anti-Cytochrome b5
Cb5 50 uL
EUR 280
Serpin B5 Conjugated Antibody
C34298 100ul
EUR 397
Serpin B5 (SERPINB5) Antibody
20-abx321461
  • EUR 300.00
  • EUR 244.00
  • 100 ul
  • 50 ul
  • Shipped within 5-10 working days.
Serpin B5 (SERPINB5) Antibody
20-abx321596
  • EUR 300.00
  • EUR 244.00
  • 100 ul
  • 50 ul
  • Shipped within 5-10 working days.
Homeobox B5 (HOXB5) Antibody
20-abx325423
  • EUR 314.00
  • EUR 244.00
  • 100 ug
  • 50 ug
  • Shipped within 5-10 working days.
Cytochrome b5 Assay Kit
abx298800-100Assays 100 Assays
EUR 425
  • Shipped within 5-10 working days.
Cytochrome b5 Polyclonal Antibody
ABP51122-003ml 0.03ml
EUR 158
  • Immunogen information: Synthesized peptide derived from the Internal region of human Cytochrome b5 at AA range: 30-110
  • Applications tips:
Description: A polyclonal antibody for detection of Cytochrome b5 from Human, Mouse, Rat. This Cytochrome b5 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Cytochrome b5 at AA range: 30-110
Cytochrome b5 Polyclonal Antibody
ABP51122-01ml 0.1ml
EUR 289
  • Immunogen information: Synthesized peptide derived from the Internal region of human Cytochrome b5 at AA range: 30-110
  • Applications tips:
Description: A polyclonal antibody for detection of Cytochrome b5 from Human, Mouse, Rat. This Cytochrome b5 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Cytochrome b5 at AA range: 30-110
Cytochrome b5 Polyclonal Antibody
ABP51122-02ml 0.2ml
EUR 414
  • Immunogen information: Synthesized peptide derived from the Internal region of human Cytochrome b5 at AA range: 30-110
  • Applications tips:
Description: A polyclonal antibody for detection of Cytochrome b5 from Human, Mouse, Rat. This Cytochrome b5 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Cytochrome b5 at AA range: 30-110
Serpin B5 (SERPINB5) Antibody
20-abx001093
  • EUR 411.00
  • EUR 592.00
  • EUR 182.00
  • EUR 314.00
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul
  • Shipped within 5-10 working days.
Cytochrome b5 Polyclonal Antibody
ES2121-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against Cytochrome b5 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA
Cytochrome b5 Polyclonal Antibody
ES2121-50ul 50ul
EUR 207
Description: A Rabbit Polyclonal antibody against Cytochrome b5 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA
anti- Cytochrome b5 antibody
FNab02186 100µg
EUR 505.25
  • Immunogen: cytochrome b5 type A(microsomal)
  • Uniprot ID: P00387
  • Research Area: Metabolism
Description: Antibody raised against Cytochrome b5
Anti-Cytochrome b5 antibody
PAab02186 100 ug
EUR 355
Human Vitamin B5(VB5)
QY-E05699 96T
EUR 361
Anti-Cytochrome b5 antibody
STJ92622 200 µl
EUR 197
Description: Rabbit polyclonal to Cytochrome b5.
Anti-Cytochrome b5 (4C2)
YF-MA10219 100 ug
EUR 363
Description: Mouse monoclonal to Cytochrome b5
Anti-Cytochrome b5 (1A8)
YF-MA10220 50 ug
EUR 363
Description: Mouse monoclonal to Cytochrome b5
Anti-ARHGEF5 (3A12-B5)
YF-MA16260 100 ug
EUR 363
Description: Mouse monoclonal to ARHGEF5
Inactivated Coxsackievirus B5 Antigen
VAng-Lsx0077-inquire inquire Ask for price
Description: Coxsackievirus (B5), natural protein.
Insect Cell Medium: TNM-FH Insect Culture Medium
ABP-MED-10001 1 liter Ask for price
    • Product line: Cell Culture Reagents
    • Brand:
Insect Cell Medium: Serum-Free Insect Culture Medium
ABP-MED-10002 1 liter Ask for price
    • Product line: Cell Culture Reagents
    • Brand:
Insect Cell Medium: Grace?s Insect Medium (Unsupplemented)
ABP-MED-10004 1 liter Ask for price
    • Product line: Cell Culture Reagents
    • Brand:
Mouse IgG1 Monoclonal Clone: HPI-B5 to Proinsulin (Clone HPI-B5)
3106-100 100 ug
EUR 355
  • What are the applications and the optimal dilutions of the product Antibody against PARP (Clone 10H)for analysis? - Immunocytochemistry : 5-20 ?g/ml | Western Blot (10 ?g/ml using colorimetric methods | <2 ?g/ml for ECL) | Immunoprecipitation and ELI
  • Show more
Description: This product represents Mouse IgG1 Monoclonal Clone: HPI-B5 against Proinsulin (Clone HPI-B5)for application in Indirect ELISA, Western blot, Immunohistochemistry.The immunogen is Recombinant full length insulin.This antibody can be used for detection of the target molecule in samples from Human, bovine, pig.
EverBrite Mounting Medium
23001 10mL
EUR 178
Description: Minimum order quantity: 1 unit of 10mL
Recovery Medium - 6x12mL
1711 4/PK
EUR 128
SuperMOUNT? Mounting Medium
1211-20
EUR 201
Aqueous Mounting Medium
AR1018 10mL X5 (Enough for 800-1200 assays)
EUR 80
Antifade Mounting Medium
AR1109 10mL (for 1000 assays)
EUR 65
EC MEDIUM, MODIFIED
E05-108-10kg 10 kg
EUR 858
EC MEDIUM, MODIFIED
E05-108-2Kg 2 Kg
EUR 226
EC MEDIUM, MODIFIED
E05-108-500g 500 g
EUR 98
A-1 MEDIUM
A01-116-10kg 10 kg
EUR 1034

DORSCON Orange: En tilgang til udfordringer i et travlt fosterdiagnostikcenter midt i en world pandemi

 

The WHO declared the coronavirus illness 2019 (COVID-19) a worldwide pandemic on 11 March 2020. Classes from SARS epidemic led Singapore to develop stringent an infection management protocols in preparation for future pandemics.
Nonetheless, in contrast to SARS, COVID-19 seems to be extra transmissible and is predicted to proceed for longer. As of 14 June 2020, there have been 40,197 constructive instances with 26 deaths in Singapore, and KK Girls’s and Youngsters’s Hospital (KKH) has managed a complete of 73 instances.
Obstetrics ultrasound is an indispensable medical service and should proceed to function throughout a pandemic. A key steadiness should be struck between retaining sufferers and healthcare employees secure whereas having the ability to present high quality and immediate obstetric care.
Our Antenatal Diagnostic Centre (ADC) in KKH developed new methods to adapt to the pandemic when the nationwide Illness Outbreak Response System Situation (DORSCON) was raised from yellow to orange on 7 February 2020. On this paper, we talk about our scientific workflow to cut back the chance of transmission amongst sufferers and employees whereas minimising disruption to our providers.

Ektopisk ACTH-syndrom med forskellig oprindelse – Diagnostisk tilgang og klinisk resultat. Erfaring med et klinisk middle

Goal: Ectopic Cushing Syndrome (EAS) is a uncommon situation accountable for about 5-20% of all Cushing syndrome instances. It will increase the mortality of affected sufferers thus discovering and removing of the ACTH-producing supply permits for curing or discount of signs and serum cortisol ranges.
The purpose of this examine is to current a 20-year expertise within the prognosis and scientific course of sufferers with EAS in a single Scientific Centre in Southern Poland in addition to a comparability of scientific course and outcomes relying on the supply of ectopic ACTH production-especially neuroendocrine tumors with different neoplasms.
Strategies: Twenty-four sufferers have been concerned within the scientific examine with EAS identified on the Division of Endocrinology between years 2000 and 2018. The prognosis of EAS was based mostly on the scientific presentation, hypercortisolemia with excessive ACTH ranges, excessive dose dexamethasone suppression take a look at and/or corticotropin-releasing hormone exams. To search out the supply of ACTH numerous imaging research have been carried out.
Outcomes: Half of the sufferers have been identified with neuroendocrine tumors, whereby muscle weak spot was the main symptom. Typical cushingoid look was seen in merely a couple of sufferers, and weight reduction was extra widespread than weight achieve. Sufferers with neuroendocrine tumors had considerably greater midnight cortisol ranges than the remainder of the group.
Amongst sufferers with infections, we noticed a considerably greater concentrations of cortisol 2400 ranges in gastroenteropancreatic neuroendocrine tumors. Chromogranin A correlated considerably with potassium in sufferers with neuroendocrine tumors and there was a big correlation between ACTH degree and severity of hypokalemia.
Conclusion: EAS just isn’t widespread, but when it happens it will increase the mortality of sufferers; subsequently, it ought to be considered within the case of coexistence of extreme hypokalemia with hypertension and muscle weak spot, particularly when weight reduction happens. As a result of the prognosis of gastroenteropancreatic neuroendocrine tumor worsens the prognosis-special consideration ought to be paid to those sufferers.
 
 

Homozygot sletning af CDKN2A i ondartet lungehindekræft: Diagnostisk nytte, patientkarakteristika og overlevelse i et britisk lungehindecenter

Background: Detection of homozygous deletion of the p16 gene (CDKN2A) by fluorescence in situ hybridization (FISH) has been investigated as an ancillary approach within the prognosis of malignant mesothelioma.
Technique: This retrospective examine reviewed the outcomes of all p16 FISH exams carried out at a regional mesothelioma centre from February 2012 to November 2019 in instances of attainable mesothelioma to look at the diagnostic utility of this take a look at in addition to sufferers traits and survival in p16 FISH constructive mesothelioma versus p16 FISH unfavourable mesothelioma.
Outcomes: P16 FISH testing was requested in 216 pathological samples within the examine interval. The take a look at failure charge was 4% (10/216). Median time from request to end result was 10 days (IQR 7-13, vary 1-30). The sensitivity, specificity, NPV and PPV have been 60 %, 100 %, 39 % and 100 % respectively.
There have been no false constructive outcomes and this genetic aberration was solely detected in instances of mesothelioma. The prevalence of p16 FISH constructive mesothelioma was greater in cytological specimens in comparison with histological specimens (75 % vs 58 %, p = 0.03) and decrease in ladies in comparison with males (33 % vs 66 %, p = 0.003).
P16 FISH constructive mesothelioma was related to considerably worse survival (median total survival 285 vs 339 days, p = 0.0018). This remained important after adjusting for confounding variables (OR 4.4, 95 %CI 1.84-11.14, p = 0.001).
Conclusions: On this examine, 60 % of mesotheliomas harbour a homozygous deletion of CDKN2A and will be precisely, reliably and effectively recognized by p16 FISH testing. This take a look at will be embedded inside routine follow in mesothelioma pathways to reinforce diagnostic accuracy.
Key phrases: CDKN2A; Mesothelioma; p16 FISH.
 
, , , , , , , , , , , , , , , , , , , , , , ,

Post navigation

Leave a Reply

Your email address will not be published. Required fields are marked *